Burney Co. Sells 793 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Burney Co. lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,325 shares of the company’s stock after selling 793 shares during the quarter. Burney Co.’s holdings in HCA Healthcare were worth $10,603,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of HCA. FMR LLC lifted its position in HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the last quarter. Franklin Resources Inc. grew its position in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock worth $660,842,000 after acquiring an additional 174,946 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after purchasing an additional 41,190 shares during the period. Janus Henderson Group PLC increased its position in shares of HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock valued at $544,467,000 after purchasing an additional 143,995 shares during the last quarter. Finally, Darsana Capital Partners LP lifted its position in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 0.5 %

HCA stock opened at $307.29 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 52 week low of $276.50 and a 52 week high of $417.14. The stock has a market capitalization of $77.84 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. The firm has a 50 day moving average of $319.34 and a 200 day moving average of $353.44.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.86%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on HCA shares. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Barclays cut their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. TD Cowen reduced their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Morgan Stanley lowered their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.